Netflix Free Google Slides... FINA BOOK 121% + Unit 1 - Case Study Assignment Respond to the following scenario: Isabella Molina is chief executive officer of Big Pharm, Inc., a Texas-headquartered company that manufactures a vaccine called MalShield, which provides some defense against malaria. Although malaria has largely been eliminated in some parts of the world, it appears to be resurging in others. Big Pharm began marketing MalShield throughout Asia. After numerous media reports that malaria was resurging in more and more places worldwide epidemic, the demand for MalShield increased, sales soared, and Big Pharm earned was soon earning record profits. Molina then began receiving disturbing reports from Southeast Asia that in some patients, MalShield had caused psychiatric disturbances, including severe hallucinations, as well as heart and lung problems. Molina was informed that six children in Japan had committed suicide by jumping out of windows after receiving the vaccine. To cover up the story and prevent negative publicity, Molina instructed Big Pharm's partners in Asia to offer cash to the Japanese families whose children had died in exchange for their silence. Molina also refused to authorize additional research within the company to study the potential side effects of MalShield. Using the information presented in Chapter 5, answer the following questions: 1. This scenario illustrates one of the main reasons why ethical problems occur in business. What is the reason? 2. Would a person who adheres to the principle of rights consider it ethical for Molina not to disclose potential safety concerns and to refuse to perform additional research on MalShield? Why or why not? 3. If MalShield prevented fifty Asian people who were infected with malaria from dying, would Molina's conduct in this situation be ethical under a utilitarian model of ethics? Why or why not? 4. Did Big Pharm or Molina violate the Foreign Corrupt Practices Act? Why or why not? W O 9 Pgon PrtSon Home End PgUp F9 F10 F7 FB F5 &